Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.
Right arrow Articles by Friedman, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Y.
Right arrow Articles by Friedman, A. D.
[Cancer Research 62, 2232-2235, April 15, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Acceleration of G1 Cooperates with Core Binding Factor ß-Smooth Muscle Myosin Heavy Chain to Induce Acute Leukemia in Mice1

Yandan Yang, Weihua Wang, Rebecca Cleaves, Marianna Zahurak, Linzhao Cheng, Curt I. Civin and Alan D. Friedman2

Department of Oncology, Johns Hopkins University, Baltimore, Maryland 21231

The genes encoding the AML1 (RUNX1) or CBFß subunits of core binding factor (CBF) are commonly altered by translocation or mutation in human leukemias. Because CBF oncoproteins slow G1, we sought to determine whether mutations that accelerate G1 potentiate their ability to induce transformation. Wild-type or p16INK4ap19ARF (-/-) marrow cells transduced with CBFß-smooth muscle myosin heavy chain (SMMHC) were transplanted into wild-type, syngeneic recipients. CBFß-SMMHC significantly increased the development of acute leukemias from marrow lacking the overlapping p16p19 genes, based on analysis of Kaplan-Meier event-time distributions. Wild-type marrow was also transduced with vectors expressing either E7 alone or both E7 and CBFß-SMMHC. Combining oncogenes again increased leukemia formation. Exposing mice transplanted with CBFß-SMMHC-transduced cells to a mutagen, ethylnitrosourea, markedly accelerated leukemogenesis compared to expressing CBFß-SMMHC with loss of p16p19, indicating the need for multiple "hits" for transformation. The INV/p16p19 and INV/E7 leukemias were lymphoid and were clonal and retransplantable. Overall, these findings indicate that CBF mutations cooperate with genetic alterations that accelerate G1 to induce acute leukemia.




This article has been cited by other articles:


Home page
BloodHome page
H.-G. Kim, K. Kojima, C. S. Swindle, C. V. Cotta, Y. Huo, V. Reddy, and C. A. Klug
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia
Blood, February 1, 2008; 111(3): 1567 - 1574.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Zhang, F. B. Fried, H. Guo, and A. D. Friedman
Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation
Blood, February 1, 2008; 111(3): 1193 - 1200.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Wunderlich, O. Krejci, J. Wei, and J. C. Mulloy
Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability
Blood, September 1, 2006; 108(5): 1690 - 1697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Moreno-Miralles, L. Pan, J. Keates-Baleeiro, K. Durst-Goodwin, C. Yang, H.-G. Kim, M. A. Thompson, C. A. Klug, J. L. Cleveland, and S. W. Hiebert
The inv(16) Cooperates with ARF Haploinsufficiency to Induce Acute Myeloid Leukemia
J. Biol. Chem., December 2, 2005; 280(48): 40097 - 40103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Bernardin-Fried, T. Kummalue, S. Leijen, M. I. Collector, K. Ravid, and A. D. Friedman
AML1/RUNX1 Increases During G1 to S Cell Cycle Progression Independent of Cytokine-dependent Phosphorylation and Induces Cyclin D3 Gene Expression
J. Biol. Chem., April 9, 2004; 279(15): 15678 - 15687.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. L. Durst, B. Lutterbach, T. Kummalue, A. D. Friedman, and S. W. Hiebert
The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain
Mol. Cell. Biol., January 15, 2003; 23(2): 607 - 619.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Kummalue, J. Lou, and A. D. Friedman
Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBF{beta}-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein
Mol. Cell. Biol., December 1, 2002; 22(23): 8278 - 8291.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Bernardin, Y. Yang, R. Cleaves, M. Zahurak, L. Cheng, C. I. Civin, and A. D. Friedman
TEL-AML1, Expressed from t(12;21) in Human Acute Lymphocytic Leukemia, Induces Acute Leukemia in Mice
Cancer Res., July 15, 2002; 62(14): 3904 - 3908.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.